1973-04-2Relevant articles and documents
N-methyltriazine synthesis method
-
Paragraph 0021-0024; 0029-0032; 0037-0040; 0045-0048, (2021/04/26)
The invention discloses an N-methyltriazine synthesis method, which comprises the following steps of S1, dissolving cyanogen chloride and acetonitrile in a solvent, adding a catalyst and hydrogen chloride, and carrying out a reaction to obtain 2-methyl-4, 6-dichloro-1, 3, 5-s-triazine, S2, enabling 2-methyl-4, 6-dichloro-1, 3, 5-s-triazine to react with sodium methoxide to obtain 2-methyl-4-methoxy-6-chloro-1, 3, 5-s-triazine, and S3, carrying out condensation reaction on the 2-methyl-4-methoxy-6-chloro-1, 3, 5-s-triazine and methylamine to obtain the N-methyl triazine. The invention provides a novel reaction route for synthesizing N-methyltriazine, the cost of used raw materials is low, the yield of synthesized N-methyltriazine is high and reaches 96% or above, potential safety hazards caused by chlorine and Grignard reagents used in a traditional synthesis method are avoided, and industrial production is facilitated.
SARs of a novel series of s-triazine compounds targeting vimentin to induce methuotic phenotype
Zhang, Lei,Qu, Zhipeng,Wu, Jianping,Yao, Shining,Zhang, Qingqing,Zhang, Tao,Mo, Lian,Yao, Qizheng,Xu, Ying,Chen, Ruihuan
, (2021/02/09)
Herein, we describe the design, synthesis and structure?activity relationships of a series of novel s-triazine compounds can induce methuotic phenotype in various types of cancer cells. (E)-1-(4-Chlorophenyl)-3-(4-((4-morpholino-6-styryl-1,3,5-triazine-2-yl)amino)phenyl)urea, compound V6, exhibited a striking methuotic phenotype with a minimal effective concentration of less than 10 nM in U87 glioblastoma cells. Based on structure?activity relationship studies, we designed and synthesized an active probe P1 that retained the full potential of V6 in inducing the methuotic phenotype in U87 glioblastoma cells. Using this probe following affinity-based proteomic profiling strategy, we identified vimentin as the specific target protein of compound V6. Molecular docking revealed that V6 can form hydrogen bonds with vimentin at 273R and 276Y in its rod domain.
NOVEL 2,4,6-TRISUBSTITUTED S-TRIAZINE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF
-
Paragraph 0069, (2019/04/05)
The present invention provides a 2,4,6-trisubstituted s-triazine compound represented by general formula (I) or pharmaceutically acceptable salts, prodrugs or solvates thereof, a preparation method therefor, and use of these compounds in preparing drugs for preventing or treating diseases associated with protein kinase and vimentin dysregulation, and cell vacuolization, and in particular, drugs for treating or preventing cancer growth and metastasis, tissue fibrosis and atherosclerosis.